breast cancer
By Larry Wickerham, MD, and Harry D. Bear, MD, PhD / 2014 San Antonio Breast Cancer Symposium
Larry Wickerham, MD, and Harry D. Bear, MD, PhD, discuss three clinical trials: • B-40, the only study to combine neoadjuvant and adjuvant chemotherapy with bevacizumab• B-51, on radiation to the chest wall• Alliance trial, on lymph node dissection